Director Daniels buys 2,000 ATEX shares at $32.75; company unprofitable with $-12.8M net income.
Leslie B. Daniels, a director, purchased 2,000 shares of Anterix Inc. at $32.75 on 2024-11-20, establishing an initial position. The purchase occurs in a company context marked by significant operational challenge: Anterix reported a net income of $-12.8M over its most recent full fiscal year, despite posting strong annual revenue growth of +118.4%. At the transaction price of $32.75, the stock was trading -20.1% from its 52-week high of $42.18, though current price of $33.72 is only slightly above the purchase price. The combination of director participation in an open-market purchase alongside steep recent losses and depressed valuation relative to the 52-week range presents a mixed signal that warrants examination of the director's prior transaction history and the company's path to profitability.